Last updated on July 2019

DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis

Brief description of study

This is a randomized, double-blind, placebo-controlled, parallel group, multi-center trial of a single administration of DaxibotulinumtoxinA (DAXI) (high-dose; low-dose) for injection versus placebo for the management of Plantar Fasciitis.

Detailed Study Description

Approximately 150 subjects, recruited from approximately 20 study centers in the United States (US) will be randomized to DAXI (HIGH-dose; LOW-dose) or placebo group, respectively.

Clinical Study Identifier: NCT03825315

Find a site near you

Start Over

Rocky Mountain Foot and Ankle, LLC

Salt Lake City, UT United States
  Connect »